Press release
Axial Spondyloarthritis (AxSpA) Global Market is Expected to Grow $7.55 Billion at a CAGR of 8.1% By 2027 | Key Players: Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A, AstraZeneca plc.
Axial Spondyloarthritis (AxSpA) Market
The Business Research Company's Axial Spondyloarthritis (AxSpA) Global Market Report 2023 identifies the increasing prevalence of spondyloarthritis is expected to propel the growth of the axial spondyloarthritis (axSpa) market going forward. Spondyloarthritis is a chronic illness that typically affects the axial skeleton, including the spine and sacroiliac joints.
The global axial spondyloarthritis (axSpA) market is expected to grow from $5.07 billion in 2022 to $5.54 billion in 2023 at a compound annual growth rate (CAGR) of 9.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The axial spondyloarthritis (axSpA) market is expected to reach $7.55 billion in 2027 at a CAGR of 8.1%.
Download Free Sample of Axial Spondyloarthritis (AxSpA) Market Report
https://www.thebusinessresearchcompany.com/sample_request?id=12590&type=smp
Major players in the axial spondyloarthritis (axspa) market are Johnson and Johnson Private Limited, Pfizer Inc., F. Hoffmann-La Roche AG, Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc., Abbott Laboratories, GSK plc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH., Horizon Therapeutics Public Ltd Co, Mitsubishi Tanabe Pharma Corporation, Ipsen Technologies Pvt Ltd., Kyowa Kirin Co. Ltd., Sun Pharmaceutical Industries Ltd., Acelyrin Inc., Nordic Bioscience A/S, Iroko Pharmaceuticals LLC, Celgene Corporation, and Pozen Inc.
Product innovations are the key trend gaining popularity in the axial spondyloarthritis (axSpA) market. Major companies operating in the axial spondyloarthritis (axSpA) market are developing new drugs to sustain their position in the market.
Read More On The Global Axial Spondyloarthritis (AxSpA) Market Report Here:
https://www.thebusinessresearchcompany.com/report/axial-spondyloarthritis-axspa-global-market-report
The Axial Spondyloarthritis (AxSpA) Market Is Segmented -
• By Types: Ankylosing spondylitis (AS), Non-radiographic axial spondyloarthritis (nr-axSpA)
• By Commercialized Therapies: Anti-tumor Necrosis Factor Therapy (TNF), Anti-Interleukin Therapy (IL), Anti-Janus Kinase Therapy (JAK)
• By Dosage Form: Tablets, Injections
• By Treatment: Tumor necrosis factor (TNF) Alpha Inhibitors, Non-steroidal anti-inflammatory drugs (NSAID), Conventional Disease Modifying Anti-Rheumatic Drugs, Glucocorticoids, Interleukin Blockers
• By End-Use: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacy Stores
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Axial Spondyloarthritis (AxSpA) market.
The Business Research Company's "Global Axial Spondyloarthritis (AxSpA) Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Axial Spondyloarthritis (AxSpA) Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12590
The Table Of Content For The Axial Spondyloarthritis (AxSpA) Market Include:
1. Executive Summary
2. Axial Spondyloarthritis (AxSpA) Market Characteristics
3. Axial Spondyloarthritis (AxSpA) Market Trends And Strategies
4. Axial Spondyloarthritis (AxSpA) Market - Macro Economic Scenario
5. Axial Spondyloarthritis (AxSpA) Market Size And Growth
.....
26. Africa Axial Spondyloarthritis (AxSpA) Market
27. Axial Spondyloarthritis (AxSpA) Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Axial Spondyloarthritis (AxSpA) Market
29. Axial Spondyloarthritis (AxSpA) Market Future Outlook and Potential Analysis
30. Appendix
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Axial Spondyloarthritis (AxSpA) Global Market is Expected to Grow $7.55 Billion at a CAGR of 8.1% By 2027 | Key Players: Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A, AstraZeneca plc. here
News-ID: 3263683 • Views: …
More Releases from The Business research company
In-Depth Examination of Segments, Industry Trends, and Key Players in the Antimi …
The antimicrobial food disinfectant sector is gaining momentum as global emphasis on food safety intensifies. With growing consumer awareness and stricter regulations, this market is positioned for substantial growth in the coming years. Let's explore the current market landscape, key players, emerging trends, and the primary segments that define this evolving industry.
Projected Market Value of the Antimicrobial Food Disinfectant Market by 2030
The antimicrobial food disinfectant market is anticipated…
Key Factors and Emerging Trends Shaping the Arachidonic Acid Market Landscape
Exploring the Future of the Arachidonic Acid Market
The arachidonic acid market is poised for significant expansion over the coming years, driven by evolving consumer needs and technological advancements. This sector is gaining momentum as it addresses various health and nutrition demands, making it an important area of growth within the broader biochemical and nutritional industries. Let's delve into the market's projected size, key players, and primary segments shaping…
Top Players and Competitive Dynamics in the Ammonium Sulfate Market
The ammonium sulfate market is positioned for substantial growth as demand for efficient and sustainable agricultural inputs continues to rise worldwide. With its multifaceted applications and increasing adoption in various industries, this market is expected to experience notable expansion in the coming years. Let's delve into the market size projections, key players, emerging trends, and the segmentation that shape this sector's future.
Projected Market Size Growth for the Ammonium Sulfate Market…
Emerging Sub-Segments Transforming the Antifog Coatings Market Landscape
The antifog coatings market is set to experience significant growth over the coming years, driven by multiple evolving applications and technological advancements. As demand grows for clearer, more durable surfaces that resist fogging, this sector is attracting considerable attention from manufacturers and end-users alike. Let's explore the anticipated market size, leading companies, emerging trends, and key segments shaping the antifog coatings landscape.
Antifog Coatings Market Size and Its Expected Growth by…
More Releases for Spondyloarthritis
Axial Spondyloarthritis Market Projected to Reach USD 5 Billion by 2034
Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease primarily affecting the spine and sacroiliac joints. It includes both radiographic axSpA (ankylosing spondylitis, AS) and non-radiographic axSpA (nr-axSpA). Symptoms such as chronic back pain, stiffness, and fatigue severely impact quality of life, often emerging in young adults.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71307
Over the past two decades, management of axSpA has advanced significantly, moving from NSAIDs and…
Axial Spondyloarthritis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Axial Spondyloarthritis Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Axial Spondyloarthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Axial Spondyloarthritis Research. Learn more about…
Axial Spondyloarthritis (axSpA) Industry - Key Market Dynamics and Trends
The axial spondyloarthritis (axspa) market size has grown strongly in recent years. It will grow from $5.54 billion in 2023 to $6.04 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to improved diagnostic criteria, biological treatment advancements, rising disease awareness, genetic research advances, clinical trial progress.
The axial spondyloarthritis (axspa) market size is expected to see…
Axial Spondyloarthritis Drug Market to see Rapid Growth by 2029
The global axial spondyloarthritis drug market is anticipated to grow at a considerable CAGR of 4.1% during the forecast period. The market is primarily driven by favourable conditions for pharmaceutical producers and the attention of various government agencies on enhancing the current healthcare infrastructure. These will lead to a rise in global demand for various drugs for treatment options for axial spondyloarthritis in the near future. Additionally, significant investment in research and…
Optimization Of Workflows To Catalyse The Axial Spondyloarthritis Treatment Mark …
Axial spondyloarthritis is a type of inflammatory arthritis which primarily affects the axial skeleton such as pelvic joints and spine. Generally ankylosing spondylitis (AS), an inflammatory disease of the sacroiliac joints and spine are collectively termed as axial spondyloarthritis.
The axial spondyloarthritis is divided in two stages namely non- radiographic and radiographic stage. Severe and chronic back pain is the major symptom of this complication along with buttock pain and pain…
Axial Spondyloarthritis Global Clinical Trials Review, H1, 2017
"The Report Axial Spondyloarthritis Global Clinical Trials Review, H1, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Axial Spondyloarthritis Market
Summary
GlobalData's clinical trial report, Axial Spondyloarthritis Global Clinical Trials Review, H1, 2017" provides an overview of Axial Spondyloarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Axial Spondyloarthritis. Report includes an overview of trial…
